iCoreConnect Inc. (NASDAQ:ICCT) Short Interest Down 84.1% in March

iCoreConnect Inc. (NASDAQ:ICCT) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 40,600 shares, a drop of 84.1% from the February 28th total of 254,700 shares. Based on an average daily trading volume, of 794,400 shares, the days-to-cover ratio is presently 0.1 days. Currently, 2.4% of the company’s shares are sold short.

iCoreConnect Trading Up 3.9 %

ICCT traded up $0.02 on Wednesday, hitting $0.40. 6,747,169 shares of the company were exchanged, compared to its average volume of 334,853. The firm has a fifty day simple moving average of $1.60 and a two-hundred day simple moving average of $3.81. iCoreConnect has a 12 month low of $0.31 and a 12 month high of $35.80. The stock has a market capitalization of $829,407.30, a PE ratio of -0.01 and a beta of 1.09. The company has a debt-to-equity ratio of 7.93, a quick ratio of 0.11 and a current ratio of 0.11.

Hedge Funds Weigh In On iCoreConnect

An institutional investor recently bought a new position in iCoreConnect stock. Virtu Financial LLC acquired a new stake in shares of iCoreConnect Inc. (NASDAQ:ICCT) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 12,698 shares of the company’s stock, valued at approximately $32,000. Virtu Financial LLC owned 1.04% of iCoreConnect at the end of the most recent quarter. 13.42% of the stock is currently owned by institutional investors and hedge funds.

About iCoreConnect

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.